Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Argus Health
US Department of Justice
Boehringer Ingelheim
Cipla
Cantor Fitzgerald
Mallinckrodt
Moodys

Generated: May 27, 2018

DrugPatentWatch Database Preview

Hikma Farmaceutica Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?

HIKMA FARMACEUTICA has forty-five approved drugs.



Summary for Hikma Farmaceutica
US Patents:0
Tradenames:41
Ingredients:34
NDAs:45

Drugs and US Patents for Hikma Farmaceutica

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 202651-001 Aug 9, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica FOSPHENYTOIN SODIUM fosphenytoin sodium INJECTABLE;INJECTION 078765-001 Dec 2, 2009 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica ENALAPRILAT enalaprilat INJECTABLE;INJECTION 078687-001 Dec 23, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065342-001 Jan 10, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Queensland Health
Harvard Business School
Moodys
US Department of Justice
Covington
Daiichi Sankyo
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.